MedPath

Clinical Study of Pregnant Women With COVID-19

Conditions
Covid-19
Registration Number
NCT04701944
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

A new pandemic, COVID-19, has spread rapidly around the world. She does not spare pregnant women. Little is known about the clinical course of pregnant women infected with COVID-19. As of April 1, 2020, six case series and one case report for a total of 61 pregnancies affected by COVID-19, all from the pandemic epicenter in China, except for one state case report -Unis, have been published. These preliminary reports suggest that pregnant women are not more seriously affected than the general population and show a certain gap with what we have observed in the care of pregnant women at HUS. For these reasons, additional information, especially from parts of the world other than China, as the severity of the disease can vary from country to country, is urgently needed to determine whether pregnant women with the disease of COVID-19 will not present with severe pneumonia to COVID-19.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
54
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A retrospective review of the medical records of pregnant women with COVID-19 at the University Hospitals of StrasbourgFiles analysed retrospectively from March 01, 2020 to April 30, 2020 will be examined]
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath